FindTrial
Sign In

an observational study to find out why liver cancer returns after surgery, and the different ways it comes back, in patients in India who have had liver cancer removed.

Post-hepatectomy Early Recurrences in Hepatocellular Carcinoma: Patterns and Treatment Approvaches in the Indian Subcontinent - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/11/097087
Enrollment
336
Registered
2025-11-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C220- Liver cell carcinoma

Interventions

Intervention1: Nil: Nil Control Intervention1: NIL: NIL

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients who underwent curative resection for hepatocellular carcinoma

Exclusion criteria

Exclusion criteria: Patients who underwent exploratory Laparotomy and were deemed unresectable

Design outcomes

Primary

MeasureTime frame
recurrences and factors affecting early recurrences in HCCTimepoint: post surgery every 3 months for the first 2 years, every 6 months for the next 3 years and yearly thereafter—

Secondary

MeasureTime frame
patterns of recurrences and treatment options for these recurrences.Timepoint: post surgery every 3 months for the first 2 years, every 6 months for the next 3 years and yearly thereafter—

Countries

India

Contacts

Public ContactDr Mizelle DSilva

Tata Memorial Hospital

drmaheshgoel@gmail.com9820504492

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026